Two living kidney-transplant recipients under tacrolimus-based immunosuppressive therapy experienced severe neurotoxicity, with tonic-clonic seizures. In both cases the dosage reduction did not result in improvement of symptoms, which completely disappeared after modification of the immunosuppressive regimen from tacrolimus to cyclosporine. Severe neurotoxicity, with seizures or uncommon clinical features, such as serious myalgias, is not foreseeable. We recommend the conversion to cyclosporine-based immunosuppression in such cases. Copyright (C) 2003 S. Karger AG, Basel.
Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases
VEROUX, Pierfrancesco;VEROUX, Massimiliano;
2003-01-01
Abstract
Two living kidney-transplant recipients under tacrolimus-based immunosuppressive therapy experienced severe neurotoxicity, with tonic-clonic seizures. In both cases the dosage reduction did not result in improvement of symptoms, which completely disappeared after modification of the immunosuppressive regimen from tacrolimus to cyclosporine. Severe neurotoxicity, with seizures or uncommon clinical features, such as serious myalgias, is not foreseeable. We recommend the conversion to cyclosporine-based immunosuppression in such cases. Copyright (C) 2003 S. Karger AG, Basel.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
severe neurotxicity urol int.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
203.31 kB
Formato
Adobe PDF
|
203.31 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
